DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans
- PMID: 7777503
- PMCID: PMC41683
- DOI: 10.1073/pnas.92.12.5307
DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans
Abstract
Intramuscular injection of plasmid DNA expression vectors encoding the three envelope proteins of the hepatitis B virus (HBV) induced humoral responses in C57BL/6 mice specific to several antigenic determinants of the viral envelope. The first antibodies appeared within 1-2 weeks after injection of DNA and included antibodies of the IgM isotype. Over the next few weeks, an IgM to IgG class switch occurred, indicating helper T-lymphocyte activity. Peak IgG titers were reached by 4-8 weeks after a single DNA injection and were maintained for at least 6 months without further DNA injections. The antibodies to the envelope proteins reacted with group- and subtype-specific antigenic determinants of the HBV surface antigen (HBsAg). Expression vectors encoding the major (S) and middle (preS2 plus S) envelope proteins induced antibodies specific to the S protein and preS2 domain, and preS2 antibodies were prominent at early time points. In general, the expression vectors induced humoral responses in mice that mimic those observed in humans during the course of natural HBV infection.
Similar articles
-
DNA-based immunization against the envelope proteins of the hepatitis B virus.J Biotechnol. 1996 Jan 26;44(1-3):47-57. doi: 10.1016/0168-1656(95)00098-4. J Biotechnol. 1996. PMID: 8717386
-
Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.J Virol. 1997 Jan;71(1):169-78. doi: 10.1128/JVI.71.1.169-178.1997. J Virol. 1997. PMID: 8985336 Free PMC article.
-
Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice.Immunology. 2001 May;103(1):90-7. doi: 10.1046/j.1365-2567.2001.01202.x. Immunology. 2001. PMID: 11380696 Free PMC article.
-
Interactions of hepatitis B virus with hepatocytes: mechanism and clinical relevance.Hepatogastroenterology. 1991 Feb;38(1):10-3. Hepatogastroenterology. 1991. PMID: 1709133 Review.
-
Clinical implications of hepatitis B virus envelope protein variation.Int J Clin Lab Res. 1994;24(2):80-5. doi: 10.1007/BF02593904. Int J Clin Lab Res. 1994. PMID: 7919432 Review.
Cited by
-
Rapid-response vaccines--does DNA offer a solution?Nat Biotechnol. 2005 Sep;23(9):1059-62. doi: 10.1038/nbt0905-1059. Nat Biotechnol. 2005. PMID: 16151391 Free PMC article.
-
Immune responses induced by gene gun or intramuscular injection of DNA vaccines that express immunogenic regions of the serine repeat antigen from Plasmodium falciparum.Infect Immun. 1999 Oct;67(10):5163-9. doi: 10.1128/IAI.67.10.5163-5169.1999. Infect Immun. 1999. PMID: 10496891 Free PMC article.
-
Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients.J Virol. 2007 May;81(10):4963-72. doi: 10.1128/JVI.02619-06. Epub 2007 Mar 14. J Virol. 2007. PMID: 17360751 Free PMC article.
-
Boosting immune response to hepatitis B DNA vaccine by coadministration of Prothymosin alpha-expressing plasmid.Clin Diagn Lab Immunol. 2005 Dec;12(12):1364-9. doi: 10.1128/CDLI.12.12.1364-1369.2005. Clin Diagn Lab Immunol. 2005. PMID: 16339058 Free PMC article.
-
Humoral and cellular immunogenecity of DNA vaccine based on hepatitis B core gene in rhesus monkeys.World J Gastroenterol. 2001 Feb;7(1):102-6. doi: 10.3748/wjg.v7.i1.102. World J Gastroenterol. 2001. PMID: 11819742 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical